79 related articles for article (PubMed ID: 10071783)
1. Fluorescence techniques for fundamental and applied studies of membrane protein receptors: the 5-HT3 serotonin receptor.
Hovius R; Schmid EL; Tairi AP; Blasey H; Bernard AR; Lundström K; Vogel H
J Recept Signal Transduct Res; 1999; 19(1-4):533-45. PubMed ID: 10071783
[TBL] [Abstract][Full Text] [Related]
2. Ligand binding to the serotonin 5HT3 receptor studied with a novel fluorescent ligand.
Tairi AP; Hovius R; Pick H; Blasey H; Bernard A; Surprenant A; Lundström K; Vogel H
Biochemistry; 1998 Nov; 37(45):15850-64. PubMed ID: 9843391
[TBL] [Abstract][Full Text] [Related]
3. Monitoring expression and clustering of the ionotropic 5HT3 receptor in plasma membranes of live biological cells.
Pick H; Preuss AK; Mayer M; Wohland T; Hovius R; Vogel H
Biochemistry; 2003 Feb; 42(4):877-84. PubMed ID: 12549905
[TBL] [Abstract][Full Text] [Related]
4. Study of ligand-receptor interactions by fluorescence correlation spectroscopy with different fluorophores: evidence that the homopentameric 5-hydroxytryptamine type 3As receptor binds only one ligand.
Wohland T; Friedrich K; Hovius R; Vogel H
Biochemistry; 1999 Jul; 38(27):8671-81. PubMed ID: 10393542
[TBL] [Abstract][Full Text] [Related]
5. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
[TBL] [Abstract][Full Text] [Related]
6. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
[TBL] [Abstract][Full Text] [Related]
7. Comparison of [3H]YM060 binding to native and cloned rat 5-HT3 receptors.
Akuzawa S; Miyake A; Miyata K; Fukutomi H
Eur J Pharmacol; 1996 Jan; 296(2):227-30. PubMed ID: 8838461
[TBL] [Abstract][Full Text] [Related]
8. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
9. Screening ligands for membrane protein receptors by total internal reflection fluorescence: the 5-HT3 serotonin receptor.
Schmid EL; Tairi AP; Hovius R; Vogel H
Anal Chem; 1998 Apr; 70(7):1331-8. PubMed ID: 9553491
[TBL] [Abstract][Full Text] [Related]
10. Functional antagonistic properties of clozapine at the 5-HT3 receptor.
Hermann B; Wetzel CH; Pestel E; Zieglgänsberger W; Holsboer F; Rupprecht R
Biochem Biophys Res Commun; 1996 Aug; 225(3):957-60. PubMed ID: 8780717
[TBL] [Abstract][Full Text] [Related]
11. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Cappelli A; Anzini M; Vomero S; Mennuni L; Makovec F; Doucet E; Hamon M; Bruni G; Romeo MR; Menziani MC; De Benedetti PG; Langer T
J Med Chem; 1998 Feb; 41(5):728-41. PubMed ID: 9513601
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
[TBL] [Abstract][Full Text] [Related]
13. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
[TBL] [Abstract][Full Text] [Related]
14. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
16. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.
Kilpatrick GJ; Jones BJ; Tyers MB
Nature; 1987 Dec 24-31; 330(6150):746-8. PubMed ID: 3696238
[TBL] [Abstract][Full Text] [Related]
17. Expression of ligand-gated ion channels with the Semliki Forest virus expression system.
Lundstrom K; Michel A; Blasey H; Bernard AR; Hovius R; Vogel H; Surprenant A
J Recept Signal Transduct Res; 1997; 17(1-3):115-26. PubMed ID: 9029484
[TBL] [Abstract][Full Text] [Related]
18. Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.
Walstab J; Combrink S; Brüss M; Göthert M; Niesler B; Bönisch H
Anal Biochem; 2007 Sep; 368(2):185-92. PubMed ID: 17617370
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of the first fluorescent antagonists for human 5-HT4 receptors.
Berque-Bestel I; Soulier JL; Giner M; Rivail L; Langlois M; Sicsic S
J Med Chem; 2003 Jun; 46(13):2606-20. PubMed ID: 12801225
[TBL] [Abstract][Full Text] [Related]
20. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
